Related Experiment Videos
Severe hepatic side effects of ezetimibe.
Mark F J Stolk1, Marco C J M Becx, Karel C Kuypers
1Department of Gastroenterology, St. Antonius Hospital, Nieuwegein, The Netherlands. m.stolk@antonius.net
Summary
Ezetimibe, a cholesterol-lowering drug, can rarely cause severe liver damage, including cholestatic or autoimmune hepatitis. This highlights the importance of monitoring liver function in patients taking ezetimibe.
Area of Science:
- Hepatology
- Pharmacology
- Internal Medicine
Background:
- Ezetimibe is a novel cholesterol-lowering medication.
- Previous reports indicated only minor elevations in transaminase levels.
Observation:
- The study observed two patients experiencing severe hepatic side effects.
- These cases occurred in a community hospital setting.
Findings:
- Ezetimibe can manifest in two distinct forms of severe liver injury.
- These include hepatotoxicity, severe cholestatic hepatitis, and acute autoimmune hepatitis.
Implications:
- Ezetimibe use may be associated with rare but serious liver toxicity.
- Clinicians should consider monitoring liver function in patients prescribed ezetimibe.
- Further research into ezetimibe-induced liver injury is warranted.